LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | JW-7-24-1 | 3.33 | uM | LJP6 | 72 | hr | 962 | 6900 | 10605 | 0.6507 | 0.6158 |
MCF 10A | Lapatinib | 3.33 | uM | LJP6 | 72 | hr | 962 | 8583 | 10605 | 0.8094 | 0.7903 |
MCF 10A | LDN-193189 | 3.33 | uM | LJP5 | 72 | hr | 962 | 2316 | 10605 | 0.2185 | 0.1405 |
MCF 10A | Linifanib | 3.33 | uM | LJP6 | 72 | hr | 962 | 11160 | 10605 | 1.0524 | 1.0576 |
MCF 10A | Linsitinib | 3.33 | uM | LJP5 | 72 | hr | 962 | 9064 | 10605 | 0.8547 | 0.8402 |
MCF 10A | Mitoxantrone | 3.33 | uM | LJP5 | 72 | hr | 962 | 380 | 10605 | 0.0359 | -0.0603 |
MCF 10A | Mitoxantrone | 3.33 | uM | LJP6 | 72 | hr | 962 | 460 | 10605 | 0.0434 | -0.0520 |
MCF 10A | MK2206 | 3.33 | uM | LJP6 | 72 | hr | 962 | 7707 | 10605 | 0.7268 | 0.6995 |
MCF 10A | Neratinib | 3.33 | uM | LJP5 | 72 | hr | 962 | 1517 | 10605 | 0.1431 | 0.0576 |
MCF 10A | Nilotinib | 3.33 | uM | LJP5 | 72 | hr | 962 | 9492 | 10605 | 0.8951 | 0.8846 |
MCF 10A | Nintedanib | 3.33 | uM | LJP6 | 72 | hr | 962 | 10662 | 10605 | 1.0054 | 1.0059 |
MCF 10A | NU7441 | 3.33 | uM | LJP5 | 72 | hr | 962 | 8446 | 10605 | 0.7964 | 0.7761 |
MCF 10A | Dactolisib | 3.33 | uM | LJP5 | 72 | hr | 962 | 1436 | 10605 | 0.1354 | 0.0491 |
MCF 10A | NVP-TAE684 | 3.33 | uM | LJP6 | 72 | hr | 962 | 4458 | 10605 | 0.4204 | 0.3626 |
MCF 10A | Palbociclib | 3.33 | uM | LJP6 | 72 | hr | 962 | 4065 | 10605 | 0.3834 | 0.3218 |
MCF 10A | PD0325901 | 3.33 | uM | LJP5 | 72 | hr | 962 | 1867 | 10605 | 0.1761 | 0.0939 |
MCF 10A | PD0325901 | 3.33 | uM | LJP6 | 72 | hr | 962 | 1133 | 10605 | 0.1069 | 0.0178 |
MCF 10A | PD173074 | 3.33 | uM | LJP6 | 72 | hr | 962 | 10254 | 10605 | 0.9669 | 0.9636 |
MCF 10A | PD184352 | 3.33 | uM | LJP5 | 72 | hr | 962 | 2663 | 10605 | 0.2511 | 0.1764 |
MCF 10A | Pelitinib | 3.33 | uM | LJP5 | 72 | hr | 962 | 1435 | 10605 | 0.1353 | 0.0491 |
MCF 10A | PF431396 | 3.33 | uM | LJP5 | 72 | hr | 962 | 1103 | 10605 | 0.1040 | 0.0146 |
MCF 10A | PF477736 | 3.33 | uM | LJP5 | 72 | hr | 962 | 1786 | 10605 | 0.1685 | 0.0855 |
MCF 10A | PF562271 | 3.33 | uM | LJP6 | 72 | hr | 962 | 1254 | 10605 | 0.1182 | 0.0303 |
MCF 10A | PHA-665752 | 3.33 | uM | LJP5 | 72 | hr | 962 | 9974 | 10605 | 0.9406 | 0.9346 |
MCF 10A | PHA-793887 | 3.33 | uM | LJP6 | 72 | hr | 962 | 604 | 10605 | 0.0570 | -0.0371 |